Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000123641 | SCV000166980 | benign | not specified | 2013-01-26 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000631745 | SCV000752835 | benign | Long QT syndrome | 2024-10-29 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001811986 | SCV002050053 | likely benign | not provided | 2021-11-09 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002253231 | SCV002525037 | benign | Cardiac arrhythmia, ankyrin-B-related | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002354310 | SCV002621093 | likely benign | Cardiovascular phenotype | 2018-12-05 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV001811986 | SCV004701233 | likely benign | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | ANK2: BP4, BP7 |